Clinical Trials in Phoenix

Showing 5381-5400 of 12,606 trials

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B

NCT03075670

This trial is conducted in Europe and the United States of America. The aim of this trial is to compare the pharmacokinetics (the exposure of the trial drug in the body) of nonacog beta pegol (N9-GP) and ALPROLIX® in patients with haemophilia B.

Congenital Bleeding DisorderHaemophilia B

Novo Nordisk A/S15 participantsStarted Mar 2017

Phoenix, Arizona, United States • Chicago, Illinois, United States • Peoria, Illinois, United States +9 more locations

TERMINATEDPhase 3< 1 mile

Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

NCT02245568

The purpose of this study is to provide subjects who have completed participation in a Phase 2 or Phase 3 trial of LMTM continued access to therapy and to evaluate the long-term safety of LMTM.

Alzheimer's DiseaseBehavioral Variant Frontotemporal Dementia

TauRx Therapeutics Ltd913 participantsStarted Aug 2014

Phoenix, Arizona, United States • Fountain Valley, California, United States • Laguna Hills, California, United States +132 more locations

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B

Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

Find Trials by Condition in Phoenix

Dimethyl Fumarate (DMF) Observational Study

Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors

A 6 Month Safety Extension Study of MBGS205

Evaluation of Preoperative N1539 in Total Knee Arthroplasty

Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer

Proof of Concept Study of Binocular Videogames Versus Patching for Amblyopia

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

Impact of Prevnar 13 on Ear Infections in Children

A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma

Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue

Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC

PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma